Outputs (9)

OA32 A national survey of rheumatology telephone adviceline support in the United Kingdom: frontline perspectives (2024)
Presentation / Conference

Background/Aims Telephone advicelines (TALs) are a core feature of rheumatology services and highly valued by patients for providing clinical advice and support. The demand for TALs has increased since the pandemic, placing pressure on current capaci... Read More about OA32 A national survey of rheumatology telephone adviceline support in the United Kingdom: frontline perspectives.

P064 It’s a long time to wait: exploring the support needs of people with rheumatoid arthritis starting methotrexate (2024)
Presentation / Conference

Background/Aims Methotrexate (MTX) is recommended as initial Disease Modifying Anti-Rheumatic Drug (DMARD) therapy for people with Rheumatoid Arthritis (RA) but often takes several months to become effective. Little is known about the support needs o... Read More about P064 It’s a long time to wait: exploring the support needs of people with rheumatoid arthritis starting methotrexate.

E006 Providing information on arthritis medication: a service evaluation (2024)
Presentation / Conference

Background/Aims Traditionally patients commencing disease modifying anti-rheumatic medications (DMARDs) attended a face to face consultation with a rheumatology nurse or pharmacist, to discuss benefits, concerns and safety monitoring. The pandemic ha... Read More about E006 Providing information on arthritis medication: a service evaluation.

The information required by people with inflammatory arthritis to take methotrexate: a mixed-methods systematic review (2024)
Journal Article

Objectives This mixed-methods systematic review aimed to identify and synthesize knowledge of the characteristics, content, and preferred format of information to support people with inflammatory arthritis (IA) to take methotrexate. Methods A literat... Read More about The information required by people with inflammatory arthritis to take methotrexate: a mixed-methods systematic review.

OP0275-HPR ‘IT’S A LOT TO TAKE IN’: A SYSTEMATIC REVIEW OF THE INFORMATION NEEDS OF PEOPLE WITH INFLAMMATORY ARTHRITIS STARTING METHOTREXATE (2023)
Presentation / Conference

Background Guidelines recommend that people with Inflammatory Arthritis have access to tailored information when starting treatment with Methotrexate (MTX) [1]. It is not known what information people with Inflammatory Arthritis (IA) need to take MTX... Read More about OP0275-HPR ‘IT’S A LOT TO TAKE IN’: A SYSTEMATIC REVIEW OF THE INFORMATION NEEDS OF PEOPLE WITH INFLAMMATORY ARTHRITIS STARTING METHOTREXATE.

E047 I felt like I’d been given a new lease of life: Exploring the information needs and experiences of people with rheumatoid arthritis receiving bridging glucocorticoids when starting methotrexate (2023)
Presentation / Conference

P015 Rheumatology advice lines: how to manage rising demand and limited capacity? (2023)
Presentation / Conference

E008 I feel a bit happier about going on it now: exploring the information needs of people starting methotrexate (2023)
Presentation / Conference

Exploring the physical, psychological and social well-being of people with rheumatoid arthritis during the coronavirus pandemic: a single-centre, longitudinal, qualitative interview study in the UK (2022)
Journal Article

OBJECTIVE: Rheumatoid arthritis (RA) is an autoimmune, inflammatory, systemic condition that requires specific drug treatment to suppress disease activity and prevent joint deformity. To manage the ongoing symptoms of joint pain and fatigue patients... Read More about Exploring the physical, psychological and social well-being of people with rheumatoid arthritis during the coronavirus pandemic: a single-centre, longitudinal, qualitative interview study in the UK.